1. Home
  2. CUE vs ESP Comparison

CUE vs ESP Comparison

Compare CUE & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • ESP
  • Stock Information
  • Founded
  • CUE 2014
  • ESP 1928
  • Country
  • CUE United States
  • ESP United States
  • Employees
  • CUE N/A
  • ESP N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • CUE Health Care
  • ESP Technology
  • Exchange
  • CUE Nasdaq
  • ESP Nasdaq
  • Market Cap
  • CUE 94.4M
  • ESP 84.1M
  • IPO Year
  • CUE 2018
  • ESP N/A
  • Fundamental
  • Price
  • CUE $0.96
  • ESP $26.95
  • Analyst Decision
  • CUE Strong Buy
  • ESP
  • Analyst Count
  • CUE 5
  • ESP 0
  • Target Price
  • CUE $5.00
  • ESP N/A
  • AVG Volume (30 Days)
  • CUE 173.5K
  • ESP 12.1K
  • Earning Date
  • CUE 05-08-2025
  • ESP 05-12-2025
  • Dividend Yield
  • CUE N/A
  • ESP 3.77%
  • EPS Growth
  • CUE N/A
  • ESP 31.14
  • EPS
  • CUE N/A
  • ESP 2.45
  • Revenue
  • CUE $9,532,000.00
  • ESP $43,917,522.00
  • Revenue This Year
  • CUE $73.11
  • ESP N/A
  • Revenue Next Year
  • CUE $11.02
  • ESP N/A
  • P/E Ratio
  • CUE N/A
  • ESP $10.81
  • Revenue Growth
  • CUE 149.53
  • ESP 18.62
  • 52 Week Low
  • CUE $0.45
  • ESP $20.20
  • 52 Week High
  • CUE $2.26
  • ESP $33.00
  • Technical
  • Relative Strength Index (RSI)
  • CUE 31.32
  • ESP 50.13
  • Support Level
  • CUE $0.98
  • ESP $26.04
  • Resistance Level
  • CUE $1.12
  • ESP $26.77
  • Average True Range (ATR)
  • CUE 0.12
  • ESP 0.78
  • MACD
  • CUE -0.03
  • ESP 0.11
  • Stochastic Oscillator
  • CUE 4.16
  • ESP 60.47

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: